Article
Intranasal gene therapy to prevent infection by SARS-CoV-2 variants
2021-04-09
Abstract excerpt
SARS-CoV-2 variants have emerged with enhanced pathogenicity and transmissibility, and escape from pre-existing immunity, suggesting first-generation vaccines and monoclonal antibodies may now be less effective. This manuscript demonstrates an approach for preventing clinical sequelae and the spread of SARS-CoV-2 variants. First, we affinity-matured an angiotensin-converting enzyme 2 (ACE2) decoy protein, achievin...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- cee29bab-cce3-51dd-b9f9-a93e37cb9a70
- DOI
- 10.1101/2021.04.09.439149
